We’re exhibiting at #SLAS2025! We’re looking forward to connecting with you in San Diego, January 25-29 at Booth #2707. Learn more: https://t.co/93DDKl691D #drugdiscovery #cartcelltherapy #epigenetics #immunotherapy #crisprcas9 #protac #scientificresearch

Huge thanks to @ucsdbiosciences and our generous sponsors @ibidiCells @BPSBioscience @NEBiolabs @NikonInst @nmdp_org @zeiss_micro & Cytoskeleton Inc. We couldn't be more grateful for your help in making this possible!

This Thanksgiving, we want to take a moment to express our heartfelt gratitude to our amazing customers and dedicated team. Thank you for being a part of our journey! 🦃💛 #Thankful #Gratitude #Thanksgiving #Appreciation #Teamwork

BPS provides the tools you need to efficiently transduce your gene of interest using lentiviruses (LV) or adeno-associated viruses (AAV). Learn more here: https://t.co/Oho44Kc8Nq #transfection #transduction #cellbiology #viraltools

BPS Bioscience’s line of luciferase-based reagents is expanding! Discover our new cellular viability reagent for metabolically active mammalian cells. Request a 50% discount on your purchase until the end of 2024. Check it out now: https://t.co/1RrmCoXcNW #cytotoxicity #cell

Happy Mole Day! https://t.co/QSQz3hX1mh

In this webinar, Junguk Park and Vanda Lopes discuss reporter cell line development and optimization in three functional categories: cytokine signaling (TSLP and IL-23), GPCR signaling (GLP-1 and MUC1), and enzyme activity (ADAR1). Watch now: https://t.co/7PKIDqOXMN

Flu season is right around the corner! Express our influenza HA-specific TCR lentivirus in one of our TCR-KO NFAT reporter cells to design a functional assay co-culturing T cells with antigen-presenting cells: https://t.co/D81kAc5YBh #drugdiscovery #TCR

Check out how our PDE enzymes were used to discover PDE11A4 Inhibitors for Age-Related Cognitive Decline: https://t.co/GrHV1maeCv https://t.co/PqXN3cjLfB #phosphodiesterase #aging #neuroscience

BPS Bioscience provides essential tools to help scientists advance projects and develop innovative therapeutic strategies. Quantify the effect of your candidate drug on TL1A, TLSP, OX40 signaling pathways, and more: https://t.co/6jsDtX6GnC

We've had a fantastic time meeting everyone at the Discovery on Target conference in Boston this week! If you haven't stopped by yet, make sure to swing by our booth and learn more about how our products can support your research. We'd love to connect! #drugdiscovery #DOT2024

Heading to the Research Supplier Product Show at John's Hopkins University today? Be sure to stop by our booth from 11am- 1pm and chat with our Sr. Territory Sales Manager, Lisa MacKenzie! She'll be there to discuss how our products can support your research needs. #drugdiscovery

BCMA is a cell surface receptor mainly expressed in mature B lymphocytes and a clinically validated oncology target. Therapeutic strategies include CAR T cells, monoclonal antibodies, antibody drug conjugates, and Bi-specific immune engagers. https://t.co/s5SeZpK6rr

Register today to attend the "Reporter Cell Line Development and Optimization for High Throughput Screening" webinar on September 24th at 2:30 PM ET! Our very own, Junguk Park & Vanda Lopes will discuss BPS luciferase reporter cell lines.

Attending the 22nd annual Discovery on Target event from Sept 30-Oct 3, 2024 in Boston? Be sure to stop by booth #305 to meet our team! We are happy to answer any questions about our products and services to assist you on your road to drug discovery! https://t.co/3jmOXdywTv

Off-the-shelf lentiviral particles transduce cells to express fluorescent protein fused to a sequence directing it to a specific subcellular structure such as nucleus, mitochondria, & β-actin cytoskeleton. Check out our new collection of lentiviruses here: https://t.co/3uXGtMxrYJ

BPS will be attending the Life Science Research Supplier Product Show at Rockefeller University today in Abby Aldrich Rockefeller Hall from 11:00 AM-1:30 PM. Stop by and meet Sr. Territory Sales Manager Megan Conlon and learn how our products can support your research!

NK cells are critical effectors in innate immunity against cancer. They have gained attention as engineered Chimeric Antigen Receptor (CAR)-expressing cells for cancer therapy.BPS provides a suite of tools to accelerate NK cell research and drug discovery: https://t.co/80T2oDYp2f

Developing targeted therapies for autoimmunity and its wide array of diseases is an emerging research area for immunotherapy and adoptive cell therapy. Take a look at our autoimmunity research products: https://t.co/oWEnHFFfVo #autoimmunity #CD19 #BCMA #TL1A

The VEGF/ VEGFR axis plays a crucial role in blood vessel formation! Its role in angiogenesis makes it a key target in treating cancers & other conditions where abnormal blood vessel formation is a concern. Discover our VEGFR reporter cell line: https://t.co/YRcm3myO0E